Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review.
作者信息
Tajika Aran, Furukawa Toshi A, Shinohara Kiyomi, Kikuchi Shino, Toyomoto Rie, Furukawa Yuki, Ito Masami, Yoshida Kazufumi, Honda Yukiko, Takayama Tomohiro, Schneider-Thoma Johannes, Leucht Stefan
机构信息
Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Kyoto, Japan
Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Kyoto, Japan.
出版信息
BMJ Ment Health. 2023 Feb;26(1). doi: 10.1136/bmjment-2023-300654.
Abstract
摘要
相似文献
1
Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review.
BMJ Ment Health. 2023 Feb;26(1). doi: 10.1136/bmjment-2023-300654.
2
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
Cochrane Database Syst Rev. 2015 Jan 16;1(1):CD009831. doi: 10.1002/14651858.CD009831.pub2.
3
Antipsychotic combinations for schizophrenia.
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD009005. doi: 10.1002/14651858.CD009005.pub2.
4
Maintenance treatment with antipsychotic drugs for schizophrenia.
Cochrane Database Syst Rev. 2012 May 16(5):CD008016. doi: 10.1002/14651858.CD008016.pub2.
5
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.
Cochrane Database Syst Rev. 2014 Jul 9;2014(7):CD009268. doi: 10.1002/14651858.CD009268.pub2.
6
Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia.
Cochrane Database Syst Rev. 2025 Apr 11;4(4):CD011885. doi: 10.1002/14651858.CD011885.pub2.
7
Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
Cochrane Database Syst Rev. 2014 Jul 8;2014(7):CD009396. doi: 10.1002/14651858.CD009396.pub2.
8
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD006324. doi: 10.1002/14651858.CD006324.pub3.
9
Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
Cochrane Database Syst Rev. 2014 Aug 3;2014(8):CD009230. doi: 10.1002/14651858.CD009230.pub2.
10
Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
Cochrane Database Syst Rev. 2014 Oct 7;2014(10):CD009369. doi: 10.1002/14651858.CD009369.pub2.
引用本文的文献
1
Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Trial.
JAMA. 2025 Sep 4. doi: 10.1001/jama.2025.13481.
2
SAS macro programme for Bang's Blinding Index to assess and visualise the success of blinding in randomised controlled trials.
Gen Psychiatr. 2024 Dec 7;37(6):e101578. doi: 10.1136/gpsych-2024-101578. eCollection 2024.
3
Are the results of open randomised controlled trials comparing antipsychotic drugs in schizophrenia biased? Exploratory meta- and subgroup analysis.
Schizophrenia (Heidelb). 2024 Feb 15;10(1):17. doi: 10.1038/s41537-024-00442-8.
本文引用的文献
1
The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis.
Lancet Psychiatry. 2022 Nov;9(11):884-893. doi: 10.1016/S2215-0366(22)00304-2. Epub 2022 Oct 10.
2
Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010.
Psychother Psychosom. 2013;82(3):152-60. doi: 10.1159/000346144. Epub 2013 Mar 21.
3
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia.
Schizophr Res. 2007 Jul;93(1-3):42-50. doi: 10.1016/j.schres.2007.03.011. Epub 2007 Apr 30.
4
Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
Int J Epidemiol. 2007 Jun;36(3):654-63. doi: 10.1093/ije/dym020. Epub 2007 Apr 17.
5
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
BMJ. 2004 Feb 21;328(7437):432. doi: 10.1136/bmj.37952.631667.EE. Epub 2004 Jan 22.
6
A study of chlorpromazine: methodology and results with chronic semi-disturbed schizophrenics.
J Nerv Ment Dis. 1955 Oct;122(4):301-14.
7
A controlled study of haloperidol in chronic schizophrenia.
Curr Ther Res Clin Exp. 1967 Aug;9(8):407-12.
8
Physician bias and the double-blind.
Arch Gen Psychiatry. 1969 Mar;20(3):315-20. doi: 10.1001/archpsyc.1969.01740150059009.
Zotero 插件